Skip to main content
Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects.
- Author(s): Hatsukami, Dorothy K;
- Luo, Xianghua;
- Heskin, Alisa K;
- Tang, Mei Kuen;
- Carmella, Steven G;
- Jensen, Joni;
- Robinson, Jason D;
- Vandrey, Ryan;
- Drobes, David J;
- Strasser, Andrew A;
- al'Absi, Mustafa;
- Leischow, Scott;
- Cinciripini, Paul M;
- Koopmeiners, Joseph;
- Ikuemonisan, Joshua;
- Benowitz, Neal L;
- Donny, Eric C;
- Hecht, Stephen S
- et al.
Published Web Locationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732016/
No data is associated with this publication.
AimA previous study showed significantly greater reductions in number of cigarettes smoked and biomarkers of toxicant and carcinogen exposure in smokers assigned to immediate reduction of nicotine in cigarettes to very low levels versus gradually over time or continued smoking of normal nicotine content cigarettes. This study examines the effects of these approaches on selected biomarkers associated with harmful biological effects.
DesignThree-arm, randomized controlled trial.
SettingTen United States academic institutional sites.
ParticipantsDaily smokers uninterested in quitting smoking with a mean age of 45.1 [standard deviation (SD) = 13.4)] years and smoking 17.1 (SD = 8.5) cigarettes/day; 43.9% (549 of 1250) female; 60.6% (758 of 1250) white ethnicity.
Interventions(1) Smoking cigarettes where nicotine content was immediately reduced to very low levels (n = 503); (2) smoking cigarettes where nicotine content was gradually reduced, with dose changes occurring monthly (n = 498); and (3) continued smoking with normal nicotine content cigarettes (n = 249).
MeasurementsSmokers were assessed at baseline while smoking their usual brand cigarettes, and again at 4, 8, 12, 16 and 20 weeks. Outcomes were areas under the concentration time curve (AUC) for the period of study of biomarkers of inflammation, oxidative stress and hematological parameters.
FindingsNo consistent significant differences were observed across groups (Bayes factors showing data to be insensitive), with the only exception being red blood cell size variability, which was observed to be lower in the immediate versus gradual nicotine reduction [mean difference = -0.11; 95% confidence interval (CI) = -0.18, -0.04, P = 0.004] and normal nicotine control groups (mean difference = - 0.15, 95% CI = -0.23, -0.06, P = 0.001).
ConclusionIt remains unclear whether switching to very low nicotine cigarettes leads to a short-term reduction in biomarkers of tobacco-related harm.
Item not freely available? Link broken?Report a problem accessing this item